---
title: "Drug-eluting Balloon Catheters Market Future Scenarios, Growth and Analytical Insights – 2029"
datePublished: Tue Feb 14 2023 12:42:21 GMT+0000 (Coordinated Universal Time)
cuid: cle48i0x7000509l85frafwdi
slug: drug-eluting-balloon-catheters-market-future-scenarios-growth-and-analytical-insights-2029
tags: news, google, hashnode

---

In 2021, the [market for drug-eluting balloon catheters](https://www.fortunebusinessinsights.com/drug-eluting-balloon-catheters-market-107028) was estimated to be worth USD 529.4 million. The market is anticipated to expand at a CAGR of 8.9% from 2022 to 2029, from USD 615.2 million to USD 1,119.4 million. Compared to pre-pandemic levels, demand for drug-eluting balloon catheters has been lower than expected across all regions due to the unprecedented and staggering COVID-19 pandemic. Our analysis showed that the global market experienced a drop of -13.7% in 2020 compared to 2019.

**Key Industry Development**

**August 2022:** To investigate the safety and effectiveness of peripheral sirolimus drug-coated balloons, BD recently announced the beginning of the first-in-human prevision trial. The study’s objective was to evaluate sirolimus’ potential as a future therapeutic option for people with Peripheral Vascular Disease (PAD).

**Access Full Report With TOC:** [https://www.fortunebusinessinsights.com/drug-eluting-balloon-catheters-market-107028](https://www.fortunebusinessinsights.com/drug-eluting-balloon-catheters-market-107028)

**Driving Factors**

**Greater Efficiency Related to Drug-eluting Balloon Catheters Over Drug-eluting Stents to Surge Demand for these Catheters**

Through minimally invasive surgery, drug-eluting balloon catheters release an anti-proliferative medication directly into the vascular wall without the use of stents. The use of these devices is a strategy that shows promise for the treatment of coronary artery disease.

Numerous studies have demonstrated the benefits of using these catheters for angioplasty in the treatment of conditions such as in-stent restenosis, high bleeding risk, and small-vessel disease.

**Segments**

**Launch of Paclitaxel-coated Balloon Catheter Products in the Market to Fuel the Segment’s Growth**

Based on drugs, the market is segregated into paclitaxel, sirolimus, and others. The paclitaxel segment generated the highest revenue in 2021 and is expected to grow at a moderate CAGR during the forecast period.

**Strong Presence of the Drug-coated Balloon Catheters for Peripheral Indication to Boost the Segment’s Growth**

Based on indication, the market is classified into coronary intervention and peripheral intervention. The peripheral segment generated the highest revenue in 2021 and is expected to grow at a substantial CAGR during the forecast period.

**Increased Preference of Patients to Visit Hospitals for Angioplasty Procedures to Fuel Segment’s Growth**

Based on end-user, the market is categorized into hospitals & Ambulatory Surgical Centers (ASCs) and speciality clinics and catheterization laboratories.  
The hospitals & ASCs segment accounted for a significant share of the market in 2021.

Geographically, the market is segregated into North America, Europe, Asia Pacific, and the Rest of the World.

**Request FREE Sample Copy of the Report:** [https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-balloon-catheters-market-107028](https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/drug-eluting-balloon-catheters-market-107028)